Growth of diabetes drug expenditure decomposed—A nationwide analysis

• Published in: Health policy (Amsterdam) Vol. 122; no. 12; pp. 1326 - 1332
• Main Authors: Soppi, Aarni, Heino, Pekka, Kurko, Terhi, Maljanen, Timo, Saastamoinen, Leena, Aaltonen, Katri
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 01.12.2018; Elsevier Science Ltd
• Subjects: Antidiabetics; Change agents; Data analysis; Diabetes; Diabetes drugs; Drug expenditures; Drugs; Expenditures; Fisher’s ideal index; Generic prescribing; Growth; Health administration; Indexes; Insulin; Per capita; Prices; Purchasing; Diabetes drugs; Growth; Fisher’s ideal index; Drug expenditures

•Volume growth and switches to newer drugs were the main cost drivers.•Price changes had decreasing effect on the overall diabetes drug expenditure.•Different sources of expenditure increase require different actions. The aim of this study was to quantify different factors underlying the growth of d...